Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Schoemaker

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Epilepsy Research|November 12, 2018
Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in childrenJulia Winkler, Rik Schoemaker, Armel Stockis
Journal of Clinical Pharmacology|November 15, 2018
Population Pharmacokinetics of Adjunctive Lacosamide in Pediatric Patients With EpilepsyJulia Winkler, Rik Schoemaker, Armel Stockis
Journal of Clinical Pharmacology|May 6, 2016
Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset SeizuresRik Schoemaker, Janet R Wade, Armel Stockis
European Journal of Clinical Pharmacology|March 11, 2017
Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 yearsRik Schoemaker, Janet R Wade, Armel Stockis
Clinical Pharmacokinetics|September 9, 2017
Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal SeizuresRik Schoemaker, Janet R Wade, Armel Stockis
Epilepsy Research|March 22, 2024
Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetamRik Schoemaker, Walter Krauwinkel, Jan-Peer Elshoff, et al.
Epilepsy Research|October 6, 2017
Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizuresRik Schoemaker, Janet R Wade, Joseph D'Souza, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 31, 2019
Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhageRik Schoemaker, Satyaprakash Nayak, Lutz O Harnisch, et al.
Clinical Pharmacokinetics|April 23, 2025
Population Pharmacokinetics and Pharmacodynamics of Fepixnebart (LY3016859) and Epiregulin in Patients with Chronic PainDouglas E James, Jason Bailey, Jan-Stefan van der Walt, et al.
British Journal of Clinical Pharmacology|April 23, 2002
Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantationSerge Cremers, Rik Schoemaker, Robbert Bredius, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Epilepsy Research|November 12, 2018
Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in childrenJulia Winkler, Rik Schoemaker, Armel Stockis
Journal of Clinical Pharmacology|November 15, 2018
Population Pharmacokinetics of Adjunctive Lacosamide in Pediatric Patients With EpilepsyJulia Winkler, Rik Schoemaker, Armel Stockis
Journal of Clinical Pharmacology|May 6, 2016
Brivaracetam Population Pharmacokinetics and Exposure-Response Modeling in Adult Subjects With Partial-Onset SeizuresRik Schoemaker, Janet R Wade, Armel Stockis
European Journal of Clinical Pharmacology|March 11, 2017
Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 yearsRik Schoemaker, Janet R Wade, Armel Stockis
Clinical Pharmacokinetics|September 9, 2017
Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal SeizuresRik Schoemaker, Janet R Wade, Armel Stockis
Epilepsy Research|March 22, 2024
Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetamRik Schoemaker, Walter Krauwinkel, Jan-Peer Elshoff, et al.
Epilepsy Research|October 6, 2017
Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizuresRik Schoemaker, Janet R Wade, Joseph D'Souza, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 31, 2019
Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhageRik Schoemaker, Satyaprakash Nayak, Lutz O Harnisch, et al.
Clinical Pharmacokinetics|April 23, 2025
Population Pharmacokinetics and Pharmacodynamics of Fepixnebart (LY3016859) and Epiregulin in Patients with Chronic PainDouglas E James, Jason Bailey, Jan-Stefan van der Walt, et al.
British Journal of Clinical Pharmacology|April 23, 2002
Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantationSerge Cremers, Rik Schoemaker, Robbert Bredius, et al.
Pageof 2